Author Correction: Fasting-mimicking diet and hormone therapy induce breast cancer regression

Correction to: Nature https://doi.org/10.1038/s41586-020-2502-7Published online 15 July 2020

In this Article, there are several errors in the attribution of affiliations to authors. Francesca Valdemarin and Francesco Piacente should have affiliations 1 (IRCCS Ospedale Policlinico San Martino, Genoa, Italy) and 5 (Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy) rather than 1 and 2 (Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy); Lorenzo Ferrando should have affiliation 5 rather than 1; and Valerio G. Vellone should have affiliations 1 and 11 (Department of Integrated Surgical and Diagnostic Sciences, University of Genoa, Genoa, Italy) rather than 2 and 11. In Fig. 2e, the P values for the comparison of ‘TMX’ and ‘Fasting + TMX’ and for the comparison of ‘TMX’ and ‘FMD + TMX’ should both be 0.0001 instead of 0.6873. In the Methods section ‘Cell lines and reagents’, ‘tamoxifen and V’ should read ‘tamoxifen and fulvestrant’. In the Methods section ‘Animal models’, the text ‘(experiments shown in Fig. 2c, d…)’ should read ‘(experiments shown in Fig. 2a, b…)’, and in the equation for tumour volume, the 2 should be superscript such that the equation becomes ‘tumour volume = (w² × W) × π/6’. In the first sentence of the Methods section ‘Tissue preparation, histology and immunohistochemistry’, the text ‘and breast gland’ should be removed to read ‘Tissue samples of uterus were formalin fixed…’. In the Methods section ‘Clinical studies of FMDs in patients undergoing ET for HR⁺ BC’, ‘effects of the FMD on blood growth’ should read ‘effects of the FMD on blood growth factors’. In the caption of Extended Data Fig. 1e, ‘with or without STS, TMX or FULV, or their combinations…’ should be changed to ‘with or without STS, FULV, or their combinations…’. In the legend of Extended Data Fig. 3, panel e should not be cited in the legends for Extended Data Fig. 3d and f. In addition, owing to an error during the production process, ‘EGR1’ was incorrectly defined as ‘epidermal growth factor 1’ instead of ‘early growth response protein 1’. The original Article has been corrected online.